Genomics
-
Devices & Diagnostics, Health Tech, Hospitals
Why 1 Health System Is Embedding Genomics Into Primary Care
At Northshore–Edward Elmhurst Health, all patients are offered genetic testing as part of their primary care visit. This helps clinicians create more personalized care plans and facilitates earlier disease diagnoses, said Kristen Murtos, the health system’s chief innovation and transformation officer.
-
MedCity Influencers, Devices & Diagnostics
Accelerating the Move to Precision Oncology
By continuing an open discussion on precision medicine and precision care, we can truly accelerate pharmacogenomic testing to its full potential and focus on providing the highest quality care to those who need it most.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
MedCity Influencers, BioPharma
Improving Value-based Care with Optimized Drug Therapy
Optimizing drug routines allows prescribers to make more informed decisions that reduce risk and improve quality of care. The result is better outcomes for both patients and organizations.
-
Nest Genomics Raises $8.5M to Increase Access to Patients’ Genetic Information
Nest Genomics just closed a $8.5 million seed financing round. The company provides the software infrastructure needed for health systems, clinics, drugmakers and payers to launch and scale genomic programs. It also provides tools for patients to easily access their genetic information.
-
MedCity Influencers, Consumer / Employer, Payers
Overcome Genomics Benefits Management Vulnerabilities With Vetted Expertise
Without the help of genomics specialists, it is hard for health plans to manage genomic benefits efficiently and effectively. Now is the time for health plans to evaluate their genomic benefits management programs to find the right expert guidance and utilization management support.
-
Putting patients at the center of RWD collection processes
In a recent interview, Jennifer Cubino, COO of BC Platforms, discussed regulatory differences between the U.S., the European Union and other countries amid ongoing efforts to encourage patients who want to share their data.
-
Startups, Artificial Intelligence, BioPharma
Illumina Accelerator unveils 7 genomics startups selected for latest funding cycle
Illumina Accelerator has invested in 68 companies so far, all of them startups developing genomics technologies. Seven startups comprise the latest cohort selected by the startup engine.
-
MedCity Influencers, Devices & Diagnostics
Precision medicine: A new dimension to improve care outcomes
All the hype around precision medicine can make it seem intimidating and foreign. The good news is that it does not represent a departure from current clinical practice, and it can significantly improve patient care.
-
Reimagine Healthcare: Transform healthcare in the cloud
Learn how healthcare organizations are working with Microsoft to enhance patient engagement, accelerate healthcare innovation, support collaboration, improve clinical and operational insights and transform healthcare in the cloud.
-
Improving Communication Between Patients and Providers
Sarah Shillington, Chief Customer Officer notes how Artera’s omnichannel platform works.
-
Bionano frames $90M BioDiscovery buy as way to expand genomics analysis
Bionano Genomics is acquiring genomics software firm BioDiscovery in a $90 million cash and stock deal. While both companies provide genomics analysis solutions, Bionano said combining its technology with BioDiscovery’s software will provide the integrated offering that many labs want.
-
Invitae to buy health records startup Ciitizen for $325M
Combining the two companies would allow patients to access genetic testing and their health records in one place, and make it easier for Invitae to collect and organize health records.
-
Health IT, Hospitals, Artificial Intelligence
Sema4 goes public via SPAC merger
With a goal of making precision medicine the standard of care at health systems, Sema4 struck a nearly $800 million deal with CM Life Sciences to go public. The company, which offers tools that combine genomic and clinical data to glean patient care insights, will get $500 million in cash proceeds to grow its business.
-
StartUPDATES: New developments for healthcare startups
Read new developments from Serimmune, Allelica, ForSight Robotics, Owlet Baby Care Inc., and Ascension Ventures.
-
StartUPDATES: New developments for healthcare startups
Read about news from Seven Bridges, Outcomes4Me, Carrum Health and more.